Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
7.810
+0.460 (+6.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
April 27, 2024
The $50 million purchase could turn into Nvidia's biggest investment.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The Top 3 Biotech Stocks to Buy in April 2024
April 27, 2024
Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.
Via
InvestorPlace
3 Millionaire-Maker Biotech Stocks
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
Via
The Motley Fool
Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'
April 24, 2024
Cramer recommends selling PBR, buying EPD, LNG, RXRX, and CASY. Criticisms of AVGO's licensing changes dismissed. PBR and CASY stocks rise.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
Where Will Recursion Pharmaceuticals Be in 5 Years?
April 17, 2024
A lot is riding on whether its platform is valuable, or vaporware.
Via
The Motley Fool
Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals
April 09, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Recursion Pharmaceuticals
March 04, 2024
Via
Benzinga
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
April 23, 2024
A look at the 10 clinical-stage AI-powered and psychedelic compound-based small-cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week and...
Via
Talk Markets
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
April 16, 2024
Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Via
InvestorPlace
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024
April 15, 2024
Through opportunity for growth and strong financial performance, these three Cathie Wood stocks could provide generous returns.
Via
InvestorPlace
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood's Ark Invest Sells $20M+ Coinbase Shares As Bitcoin Trades Over $70K, Buys Palantir, Sells Nvidia Stock
April 11, 2024
On Thursday, Cathie Wood’s Ark Invest made significant trades involving Coinbase Global, Inc. (NASDAQ:COIN), Palantir Technologies Inc. (NYSE:PLTR), and Nvidia Corp.
Via
Benzinga
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
April 10, 2024
Recursion is playing the long game with its AI-focused approach to drug discovery and development.
Via
The Motley Fool
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
April 08, 2024
They might not be profitable yet, but they're swinging for the fences.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Surge Ending: Only One Category Was Up This Week
April 06, 2024
Six of the 7 categories we cover dropped this week, compared with 3 in March. The data clearly indicates that the surge in this sector is stalling or perhaps is even over.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?
April 04, 2024
This stock's upside is huge, but so is its downside.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
March 31, 2024
No AI category went down in February, but 3 did in March - confirming my comment last week that
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
March 26, 2024
Via
Benzinga
Recursion Publishes Annual Environmental, Social and Governance Report
March 26, 2024
Provides progress updates in support of long-term commitments focused on reducing greenhouse gas emissions, improving workforce diversity and accelerating community impact.
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships
March 25, 2024
Nvidia announces partnerships with J&J and GE Healthcare to integrate generative AI into surgery and medical imaging at GTC AI conference. Analysts see potential for revenue growth outside tech sector....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence
March 18, 2024
Via
Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...
Via
Benzinga
Nvidia's Secret Weapon Is Not Just Chips But Investing $1.5B In AI's Rising Stars: Report Unveils CEO Jensen Huang's 10-Year Vision
March 11, 2024
Additionally, the investments help Nvidia "build out the future ecosystem of businesses that depend on its technology" even as rivals are trying to break into the chipmaker's dominance.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion Announces Plans to Open New Office in London
March 11, 2024
Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the...
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
March 07, 2024
The company just made a provocative move in one of its collaborations.
Via
The Motley Fool
The Top 7 Small-Cap Stocks to Buy in March 2024
March 04, 2024
These top small-cap stocks to buy are set for a strong 2024 as reduced inflation increases their growth prospects.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
March 04, 2024
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.